Methyl Methanesulfonate. Dimethylsulfonate . Mesilate, Methyl . Methyl Mesylate . Methyl Methylenesulfonate . Methylmesilate . Mesylate, Methyl . Methanesulfonate, Methyl . Methyl Mesilate . Methylmethane Sulfonate . An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA. . 1.00
Ethyl Methanesulfonate. Ethyl Mesilate . Ethyl Mesylate . Ethylmesilate . Ethylmesylate . Mesilate, Ethyl . Mesylate, Ethyl . Methanesulfonate, Ethyl . Sulfonate, Ethylmethane . Ethylmethane Sulfonate . An antineoplastic agent with alkylating properties. It also acts as a mutagen by damaging DNA and is used experimentally for that effect. . 0.86
Imatinib Mesylate. Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide . CGP 57148 . CGP-57148 . CGP57148B . Gleevec . Glivec . Imatinib . Imatinib Methanesulfonate . ST 1571 . ST1571 . STI 571 . STI-571 . STI571 . CGP57148 . Mesylate, Imatinib . Methanesulfonate, Imatinib . A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. . 0.71